The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
PreviousPrevious
Volume 349:1309-1311 October 2, 2003 Number 14
NextNext

Infection and Lymphoma
Richard Ambinder, M.D., Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Hjalgrim, H.
-PubMed Citation
The persistence of the eponyms "Hodgkin" and "Reed–Sternberg" and the noncommittal descriptor "disease" underscores the uncertainties long associated with the multinucleated giant cells that Sternberg believed to be a manifestation of infection and Reed believed to be malignant. In fact, it is now clear that several infections are closely linked with lymphomagenesis. These include Epstein–Barr virus (EBV) in a variety of lymphoproliferative diseases, human T-cell leukemia virus type 1 (HTLV-1) in adult T-cell leukemia–lymphoma, Helicobacter pylori in gastric mucosa-associated lymphoid-tissue lymphoma, and hepatitis C virus in splenic lymphoma with villous lymphocytes.

Broadly speaking, the infectious agents associated with lymphoma fall . . . [Full Text of this Article]


Source Information

From Johns Hopkins School of Medicine, Baltimore.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.